Skip to contentMakhzoumi Mohamad — Bright Health Group Inc. insider: 293 transactions · InsiderLensMakhzoumi Mohamad
- 10% owner at Korro Bio, Inc. · on record since Nov 7, 2023
- 10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
- 10% owner at SCHERING PLOUGH CORP · on record since Feb 11, 2026
- 10% owner at OnKure Therapeutics, Inc. · on record since Apr 15, 2021
- 10% owner at Regulus Therapeutics Inc. · on record since Jul 31, 2017
- 10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
- 10% owner at GENOCEA BIOSCIENCES, INC. · on record since Jan 23, 2018
- 10% owner at Achaogen Inc · on record since Jun 29, 2018
- 10% owner at AVEO PHARMACEUTICALS INC · on record since Jun 28, 2018
- 10% owner at ARDELYX, INC. · on record since Jul 17, 2018
- 10% owner at TAPIMMUNE INC · on record since Oct 18, 2018
- 10% owner at Tempest Therapeutics, Inc. · on record since Dec 11, 2018
- 10% owner at KNIGHT CAPITAL GROUP, INC. · on record since Jan 2, 2019
- 10% owner at Trevi Therapeutics, Inc. · on record since May 13, 2019
- 10% owner at Mirum Pharmaceuticals, Inc. · on record since Jul 24, 2019
- 10% owner at Revolution Acceleration Acquisition Corp · on record since Jul 30, 2021
- 10% owner at Black Diamond Therapeutics, Inc. · on record since Jan 29, 2020
- 10% owner at Akouos, Inc. · on record since Jun 25, 2020
- 10% owner at Inozyme Pharma, Inc. · on record since Jul 28, 2020
- 10% owner at Annexon, Inc. · on record since Jul 23, 2020
- 10% owner at Metacrine, Inc. · on record since Sep 22, 2020
- 10% owner at Nkarta, Inc. · on record since Jul 16, 2020
- 10% owner at HEARUSA INC · on record since Oct 22, 2020
- 10% owner at Dolan Media CO · on record since Dec 11, 2020
- Director at Robinhood Markets, Inc. · on record since Jul 29, 2021
- 10% owner at Robinhood Markets, Inc. · on record since Jul 29, 2021
- Former 10% Owner at Regulus Therapeutics Inc. · on record since Mar 16, 2021
- 10% owner at ADVENTRX PHARMACEUTICALS INC · on record since Mar 16, 2021
- 10% owner at Verona Pharma plc · on record since Jan 4, 2021
- Director at Bright Health Group Inc. · on record since Jun 30, 2021
- 10% owner at Bright Health Group Inc. · on record since Jun 30, 2021
- 10% owner at Monte Rosa Therapeutics, Inc. · on record since Jun 30, 2021
- 10% owner at IonQ, Inc. · on record since Oct 4, 2021
- 10% owner at Arcellx, Inc. · on record since Feb 9, 2022
- 10% owner at SENESCO TECHNOLOGIES INC · on record since Jun 15, 2022
Insider trading activity of Makhzoumi Mohamad
- Transactions on record
- 293
- since Jun 28, 2018
- Open-market buys
- 45
- $222M
- Open-market sells
- 13
- $18.4M
- Companies traded
- 23
- last filing Mar 12, 2026
Figures computed from official regulatory filings — methodology.
Companies where Makhzoumi Mohamad has traded
- Korro Bio, Inc.3 tx · $6M · Mar 12, 2026
- Trevi Therapeutics, Inc.15 tx · $40M · Feb 13, 2026
- SCHERING PLOUGH CORP13 tx · $15M · Feb 11, 2026
- Bright Health Group Inc.88 tx · $372.8M · Oct 6, 2025
- MBX Biosciences, Inc.5 tx · $8M · Sep 17, 2024
- ADVENTRX PHARMACEUTICALS INC1 tx · $1M · Jul 19, 2023
- Mirum Pharmaceuticals, Inc.8 tx · $6.8M · Jun 15, 2023
- Arcellx, Inc.7 tx · $5M · Dec 22, 2022
- Akouos, Inc.8 tx · $10M · Dec 2, 2022
Track record of Makhzoumi Mohamad
Statistical track record
Free- Open-market buys
- 58
- Last buy
- Mar 10, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Makhzoumi Mohamad
Co-insiders of Makhzoumi Mohamad
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
8 tx · $17.1M · Nov 18, 2022
NEA Partners 15, L.P.Annexon, Inc. +12
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 12, 2026 | Buy | 207,100 | 11.11 USD | $2.3M | SEC |
| Mar 12, 2026 | BuyD | 242,945 | 11.11 USD | $2.7M | SEC |
| Feb 13, 2026 | OtherD | -1,851,852 | 0.00 USD | $0 | SEC |
| Feb 13, 2026 | Other | 1,851,852 | 1.37 USD | $2.5M | SEC |
| Feb 11, 2026 | Other | 1,370,168 | — | — | SEC |
| Feb 11, 2026 | OtherD | -954,990 | — | — | SEC |
| Feb 11, 2026 | OtherD | -737,962 | — | — | SEC |
| Feb 11, 2026 | Other | 1,370,168 | — | — | SEC |
| Feb 11, 2026 | Buy | 937,500 | 16.00 USD | $15M | SEC |
| Feb 11, 2026 | Other | 402,273 | — | — | SEC |
| Feb 11, 2026 | Other | 737,962 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,370,168 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,619,240 | — | — | SEC |
| Feb 11, 2026 | OtherD | -402,273 | — | — | SEC |
| Feb 11, 2026 | Other | 954,990 | — | — | SEC |
| Feb 11, 2026 | Other | 1,619,240 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,370,168 | — | — | SEC |
| Oct 6, 2025 | Other | -2,384,873 | — | — | SEC |
| Oct 6, 2025 | Exercise | 189,195 | 0.01 USD | $1.9K | SEC |
| Oct 6, 2025 | ExerciseD | -607,536 | 0.00 USD | $0 | SEC |
| Oct 6, 2025 | OtherD | -125,000 | — | — | SEC |
| Oct 6, 2025 | Exercise | 189,195 | 0.01 USD | $1.9K | SEC |
| Oct 6, 2025 | Other | -1,159,683 | — | — | SEC |
| Oct 6, 2025 | Exercise | 607,536 | 0.01 USD | $6.1K | SEC |
| Oct 6, 2025 | Other | -280 | 6.75 USD | $1.9K | SEC |